Washington University School of Medicine

Digital Commons@Becker
Open Access Publications
2009

Ube2j2 ubiquitinates hydroxylated amino acids on ER-associated
degradation substrates
Xiaoli Wang
Washington University School of Medicine in St. Louis

Roger A. Herr
Washington University School of Medicine in St. Louis

Martijn Rabelink
Leiden University Medical Center

Rob C. Hoeben
Leiden University Medical Center

Emmanual J.H.J. Wiertz
Leiden University Medical Center

See next page for additional authors

Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs

Recommended Citation
Wang, Xiaoli; Herr, Roger A.; Rabelink, Martijn; Hoeben, Rob C.; Wiertz, Emmanual J.H.J.; and Hansen, Ted
H., ,"Ube2j2 ubiquitinates hydroxylated amino acids on ER-associated degradation substrates." The journal
of cell biology. 187,5. 655-668. (2009).
https://digitalcommons.wustl.edu/open_access_pubs/3677

This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been
accepted for inclusion in Open Access Publications by an authorized administrator of Digital Commons@Becker.
For more information, please contact vanam@wustl.edu.

Authors
Xiaoli Wang, Roger A. Herr, Martijn Rabelink, Rob C. Hoeben, Emmanual J.H.J. Wiertz, and Ted H. Hansen

This open access publication is available at Digital Commons@Becker: https://digitalcommons.wustl.edu/
open_access_pubs/3677

JCB: Article

Published November 30, 2009

Ube2j2 ubiquitinates hydroxylated amino acids on
ER-associated degradation substrates
Xiaoli Wang,1 Roger A. Herr,1 Martijn Rabelink,2 Rob C. Hoeben,2 Emmanuel J.H.J. Wiertz,3,4 and Ted H. Hansen1
1

Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110
Department of Molecular Cell Biology and 3Department of Medical Microbiology, Leiden University Medical Center, 2300 RC Leiden, Netherlands
4
Department of Medical Microbiology, University Medical Center Utrecht, 3584 CX Utrecht, Netherlands

U

biquitin (Ub) modification of proteins plays a
prominent role in the regulation of multiple cell
processes, including endoplasmic reticulum–
associated degradation (ERAD). Until recently, ubiquitination of substrates was thought to occur only via
isopeptide bonds, typically to lysine residues. Several
recent studies suggest that Ub can also be coupled to
nonlysine residues by ester/thiolester bonds; however,
the molecular basis for these novel modifications remains
elusive. To probe the mechanism and importance of nonlysine ubiquitination, we have studied the viral ligase

murine K3 (mK3), which facilitates the polyubiquitination of hydroxylated amino acids serine/threonine on its
ERAD substrate. In this paper, we identify Ube2j2 as the
primary cellular E2 recruited by the mK3 ligase, and this
E2–E3 pair is capable of conjugating Ub on lysine or
serine residues of substrates. However, surprisingly,
Ube2j2–mK3 preferentially promotes ubiquitination of
hydroxylated amino acids via ester bonds even when
lysine residues are present on wild-type substrates, thus
establishing physiological relevance of this novel ubiquitination strategy.

Introduction

Correspondence to Ted H. Hansen: hansen@pathology.wustl.edu

with the C-terminal Gly of Ub in an ATP-dependent manner.
The activated Ub is then transiently transferred to a conserved
cysteine (C) residue of an E2. Finally, the charged E2 interacts
with an E3 and facilitates the transfer of the Ub moiety to lysine
(K) residues of the substrate or less commonly to the -amino
group of the N-terminal amino acid of a substrate (Ciechanover
and Ben-Saadon, 2004). The interaction of E2–E3 is also responsible for the assembly of poly-Ub chains on substrates
(Pickart, 2001). All seven K residues of Ub have been found to
participate in the formation of poly-Ub chains in vivo. However,
the most abundant chains detected by mass spectrometry analyses of modified yeast proteins are linked through K48, K63, and
K11 residues (Peng et al., 2003; Xu et al., 2009). K48-linked
poly-Ub chains typically target the substrate for proteasomal
degradation in the cytosol, whereas K63-linked poly-Ub chains
are usually involved in endocytosis, DNA repair, and signal
transduction (Pickart and Fushman, 2004; Chen and Sun, 2009).
More recently K11-linked chains were also found to target
ERAD substrates for proteasome degradation (Jin et al., 2008;

Abbreviations used in this paper: DUB, deubiquitinating enzyme; Endo H, endo
glycosidase H; ERAD, ER-associated degradation; FII, fraction II; HC, major histo
compatibility complex class I heavy chain; KSHV, Kaposi’s sarcoma-associated
herpesvirus; mK3, murine K3; RING, really interesting new gene; shRNA, short
hairpin RNA; TMD, transmembrane domain; Ub, ubiquitin; Ub-Al, Ub aldehyde;
WT, wild type.
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Modification of proteins with ubiquitin (Ub) is involved in
almost all fundamental cellular functions, including regulation
of the cell cycle, DNA repair, apoptosis, gene expression, and
signal transduction (Hershko and Ciechanover, 1998; Fang and
Weissman, 2004). In addition, ubiquitination plays a central
role in the homeostasis and quality control of proteins expressed
by the secretory pathway. The latter function of Ub is largely
performed by ER-associated degradation (ERAD), which targets aberrant proteins for proteasome-dependent degradation
(Hampton, 2002; Kostova and Wolf, 2003; Meusser et al., 2005;
Sayeed and Ng, 2005). Not surprisingly, abnormalities in the
ubiquitination system cause numerous human diseases ranging
from neurodegenerative diseases to cancers (Glickman and
Ciechanover, 2002). Using an evolutionarily conserved mechanism, ubiquitination is performed by a cascade of three types of
enzymes: activating enzyme E1, conjugating enzyme E2, and
ligase E3. Ub is first activated by E1, which forms a thiolester
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Ube2j2 have been implicated in ERAD (Kostova et al., 2007).
In addition, cytosolic E2s such as Ube2k (also called E2-25k;
homologue of yeast Ubc1p) and Ube2d1 (homologue of yeast
Ubc5a) were reported to be involved in ERAD in mammals
(Younger et al., 2004; Flierman et al., 2006). In higher eukaryotes, including mammals, there is also a growing list of ER
membrane–associated E3 ligases (Fang et al., 2001; Didier et al.,
2003; Nadav et al., 2003; Kikkert et al., 2004; Hassink et al., 2005;
Kreft et al., 2006; Brauweiler et al., 2007; Lerner et al., 2007).
However, with the exception of the recently characterized
Ube2g2–gp78 complex (Li et al., 2007, 2009; Das et al., 2009),
the functional interaction of these E2s with their cognate E3s
has not been well characterized. Genetic studies of yeast suggested that Ubc6p interacts with ligase Doa10 to induce ubiquitination and proteasome degradation of model ERAD substrates
(Swanson et al., 2001; Ravid et al., 2006). Interestingly, Doa10
is a RING-CH–type ER membrane–bound E3 ligase similar to
mK3. However, in mammals, no cognate E3 ligases of Ube2j2
(Ubc6p homologue) have been identified.
In this study, permeabilized cells were used to show that
Ub-conjugating enzymes Ube2j2 and Ube2d1 can interact with
mK3 to promote the ubiquitination of HC substrates, whereas
other potential ERAD-associated E2s cannot interact with
mK3. Using permeabilized cells expressing mK3 and HC mutants having only 1K or 1S Ub acceptor site, Ube2d1 only
ubiquitinated K residues on HC substrates, whereas Ube2j2
could ubiquitinate either S or K residues. Interestingly, using
wild-type (WT) HC substrates, inhibition by short hairpin RNA
(shRNA) of only Ube2j2 resulted in impaired ubiquitination
and induced stabilization of HCs, demonstrating that Ube2j2 is
the primary E2 interacting with mK3 ligase in vivo. Furthermore, the Ub conjugates on the WT HC mediated by Ube2j2–
mK3 were sensitive to mild alkaline treatment, indicating that
this E2–E3 interaction strongly favors the ubiquitination of
hydroxylated residues on HC substrates even in the presence
of K residues. Importantly, the preferential ubiquitination of
hydroxylated residues of HC by Ube2j2–mK3 was not the result of differential deubiquitination by C proteases. Thus, these
findings demonstrate for the first time that the same E2–E3
complex can catalyze the coupling of Ub to substrates via
either an isopeptide bond or an ester bond and that this latter
form of nonconventional ubiquitination can be preferentially
used to induce ERAD.

Results
Membrane-bound E2s support the
ubiquitination of the HC by mK3 ligase

To test whether the cellular E2 supporting mK3 ubiquitination
of HC is membrane associated, a permeabilized cell system was
used (Shamu et al., 1999). WT3 cells expressing mK3 ligase
and its substrate Ld HCs were treated briefly with digitonin and
then centrifuged to separate cytosolic proteins in solution from
membrane proteins in the pellet. Next, pellets of permeabilized
cells were resuspended with an energy-regenerating system
(Feldman et al., 1997) and buffer containing E1, E1 + HA-Ub,
or fraction II (FII; which contains E1, most E2s, some E3s, and
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Xu et al., 2009). Despite the fact that subtle differences in the
ubiquitination of substrates dictate their fate, the mechanisms
governing substrate residue selection and Ub chain assembly
remain poorly understood. A major hindrance for addressing
this critical issue in mammals is the lack of defined E2–E3
interactions for physiological substrates.
Surprisingly, recent discoveries indicated that Ub moieties can be linked to substrates by thiolester or ester bonds.
These two types of conjugations were found to be mediated by
related viral E3 ligases that share a highly homologous RING
(really interesting new gene)-CH domain, transmembrane topology, and the ability to target major histocompatibility complex class I heavy chains (HCs) as an immune evasion strategy.
The kK3 and kK5 ligases of Kaposi’s sarcoma-associated
herpesvirus (KSHV) promote ubiquitination of C or K residues
on HC substrates, resulting in their rapid endocytosis and degradation in the lysosome (Cadwell and Coscoy, 2005, 2008). In
contrast, the murine K3 (mK3) ligase of murine -HV68 promotes the ubiquitination of hydroxylated amino acids (serine
[S] or threonine [T]) or K residues on HCs, resulting in their
ERAD (Wang et al., 2007; Herr et al., 2009). Whether the same
E2s or specialized E2s are responsible for interacting with
kK3/kK5 or mK3 to form thiolester or ester versus isopeptide
linkages has not been reported. Thus, questions remain about
the molecular mechanisms of these novel forms of non-K ubiquitination. However, there is increasing indirect evidence for
the physiological relevance of substrate ubiquitination via thio
lester or ester bonds. For example, an extensive mutagenesis
study by Tait et al. (2007) showed that apoptosis induction by
Bid requires the ubiquitination of S and C residues on its
N-terminal fragment. Furthermore, in yeast and mammals, it was
revealed that export of Pex5p, a peroxisomal import receptor, requires ubiquitination of a conserved C residue of Pex5p
(Carvalho et al., 2007; Williams et al., 2007). Thus, non-K
ubiquitination appears to be a conserved mechanism in yeast
and mammals, suggesting that it is a physiologically important
posttranslational modification.
In yeast, there are three E2s, Ubc6p, Ubc7p, and Ubc1p,
that are known to be involved in the ERAD of misfolded/
unassembled lumenal or ER membrane proteins (Chen et al.,
1993; Sommer and Jentsch, 1993; Hiller et al., 1996; Biederer
et al., 1997; Friedlander et al., 2000; Bays et al., 2001). Both
Ubc6p and Ubc7p are ER membrane associated. Interestingly, the
ERAD of different substrates mediated by the E3 ligase Hrd1/
Der3 requires predominantly Ubc7p or, less frequently, Ubc1p
(Bays et al., 2001). However, ERAD mediated by the E3 ligase
Doa10 depends exclusively on Ubc6p and Ubc7p (Swanson
et al., 2001; Ravid et al., 2006), suggesting that these E2s may
preferentially interact with E3 ligases to induce the ERAD of a
different subset of substrates (Kikkert et al., 2005; Kostova et al.,
2007). In mammals, there are two clear homologues of yeast
Ubc6p and Ubc7p named Ube2j2 and Ube2g2, respectively
(Tiwari and Weissman, 2001). In addition, homologues with less
sequence identity to yeast Ubc6p and Ubc7p have been identified in mammals and named Ube2j1 (also called Ubc6e) and
Ube2g1 (Lester et al., 2000; Lenk et al., 2002; Kostova et al.,
2007). Of the four of these homologues, Ube2g2, Ube2j1, and
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Figure 1. Membrane-bound E2s support the ubiquitination of the HC by mK3. (A) Mouse WT3 cells coexpressing WT Ld and mK3 were treated briefly
with digitonin. The cytosolic proteins (CP) in solution and membrane proteins in the pellet were separated by centrifugation. The pellet was then suspended
with reaction buffer containing an ATP-regenerating system. Three aliquots were made from this suspension and incubated with E1 only, E1 + HA-Ub
(Ub*), or rabbit reticulocyte FII + Ub*, respectively, and followed by centrifugation. Samples from supernatant (S) and pellet (P) of each group as well as
the cytosolic protein fraction were blotted by the antibodies indicated to verify the depletion of the cytosolic proteins and the maintenance of membrane
proteins in the pellet. It should be noted that FII likely contains most soluble E2s; thus, the supernatant fraction with FII added is Ube2k and Ube2n positive.
(B) Precipitations of Ld HCs from the supernatant or the pellet fractions of three reaction groups described in A were performed using anti-Ld mAbs. The
precipitates were blotted for newly formed Ub-Ld conjugates with anti-HA. An anti-Ld blot was included to show similar input in each group and as an
Endo H treatment control. Data shown are representative of three independent experiments. (A and B) Molecular mass is indicated in kilodaltons. IB, immunoblot;
IP, immunoprecipitation.

the proteasome) + HA-Ub. After incubation, the reaction mixture was separated into the supernatant and pellet fractions.
Samples from the supernatant and pellet fractions of these three
experimental groups as well as samples from the cytosolic protein fraction were tested by immunoblot to verify the elimination of cytosolic proteins (Ube2n and Ube2k) and the retention
of membrane proteins such as mK3 (Fig. 1 A). The de novo Ub
conjugates on the HCs in these supernatant and pellet fractions
were identified by immunoprecipitation of the HC and blotting
for HA. To clearly distinguish the ubiquitinated HC from nonspecific bands, half of the HC precipitates were treated with
endoglycosidase H (Endo H). This treatment cleaves the high
mannose glycan moieties from immature HCs (nonubiquitinated as well as ubiquitinated), resulting in a down shift of
corresponding HC bands in the gel. From the experiment shown
in Fig. 1 B, four important conclusions can be drawn. First,
Endo H–sensitive ubiquitinated HC bands were only observed
in the samples incubated with HA-tagged Ub (lanes 7, 8, 11,
and 12) but not in the samples without added HA-Ub (lanes
1–4). Thus, only newly ubiquitinated HCs were detected in the
HA blots. Second, the pattern of the de novo ubiquitinated HCs
in the permeabilized cells is the same as previously seen with
nonpermeabilized cells (Wang et al., 2007), demonstrating recapitulation of what is observed in vivo. Third, the ubiquitinated
HCs were only detected in the pellet, indicating that they were
membrane bound, which is consistent with in vivo observations
(Wang et al., 2007). Fourth, profound ubiquitination of HC was
detected in the samples with only E1 (lanes 7 and 8), supporting

the hypothesis that a cognate E2 of mK3 is membrane bound.
Consistent with this conclusion, samples with added FII fraction (likely containing most soluble E2s) gave less robust ubiquitination of HC (lanes 11 and 12). Furthermore, by using the
cells expressing a catalytically inactive RING mutant of mK3,
we confirmed that ubiquitination in the permeabilized system
was indeed mediated by mK3 (Fig. S1). Collectively, these data
validate the approach and further suggest that a membranebound E2 can support mK3-mediated ubiquitination of HC.
Ube2j2 supports both ester- and amidelinked ubiquitination of the HC by mK3

We next wanted to determine whether the cognate E2s of mK3
are the same or different for ubiquitination of hydroxylated
versus K residues. For this purpose, an Ld HC mutant with one
S in its native position 329 (Ld 1S) was made on a template
lacking C, K, S, and T residues on the tail (Ld ∆CKST; Fig. 2 A).
To exclude possible position effects, a similar Ld mutant was
also made by replacing Ld 329S with a K residue (Ld 1K).
Cells expressing either the 1S or 1K HC mutants and mK3
were permeabilized, and the membrane portions were incubated with E1 and E2 in the presence of ATP and HA-Ub. All
known ER membrane–associated E2s and their homologues in
the mouse (Ube2g1, Ube2g2, Ube2j1, and Ube2j2) and two
mouse cytosolic E2s, Ube2k and Ube2d1, implicated in ERAD
were tested. Ube2n was also included as a negative control.
Each of these seven E2s was expressed as a soluble recombinant protein in Escherichia coli and normalized for enzymatic
Nonconventional ubiquitination by Ube2j2–mK3 • Wang et al.
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Figure 2. Ube2j2 interacts with mK3 to promote the Ub conjugation of S or K residues, whereas Ube2d1 interacts with mK3 to promote only ubiquitination
of K residues. (A) Nomenclature and sequence alignment of the cytoplasmic tails of Ld mutants are shown with original WT residues in bold. (B) WT3 cells
coexpressing Ld 329K (1K) and mK3 were permeabilized, cytosol depleted, and incubated with E1 and selective mouse E2 in the presence of ATP and
HA-Ub. Precipitated Ld molecules (/+ Endo H) were resolved by SDS-PAGE and blotted for newly ubiquitinated Ld by anti-HA. An anti-Ld blot was included
to show similar input in each group and as an Endo H treatment control. (C) After permeabilization and centrifugation, cells used in B were incubated with
one of the four ER-associated E2s or homologues. Precipitates of Ld HCs were blotted for HA-Ub and Ld. (D and E) The same experiments were conducted
as in B and C, respectively, using cells stably expressing Ld 329S (1S) and mK3. (B–E) Data are representative of at least two independent experiments.
Molecular mass is indicated in kilodaltons. IB, immunoblot; IP, immunoprecipitation.
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activity (Fig. S2, A and B). Of the seven E2s tested, Ube2d1
and Ube2j2 were found to greatly enhance the Ub conjugation
of Ld 1K (Fig. 2, B and C). Surprisingly, Ube2j2 but not
Ube2d1 greatly enhanced the ubiquitination on Ld 1S molecules (Fig. 2, D and E). In contrast, the other four E2s did not
appreciably change the extent of ubiquitination of the HCs in
comparison with samples with Ube2n or samples without
added E2 (E1 only). Thus, Ube2j2 can cooperate with mK3 to
promote ubiquitination of either S or K residues on HC substrates, whereas Ube2d1 can only support the ubiquitination
on K and not S residues on HC substrates.
Ube2j2 is required for ubiquitination and
ERAD of HC substrates by the mK3 ligase

mK3 mediates dominant S/T
ubiquitination on the tail of Ld while
K residues are available

To determine whether mK3–Ube2j2 preferentially promotes
the formation of ester bonds, we monitored the sensitivity of
ubiquitinated HCs to mild alkaline treatment (Hershko et al.,
1980). WT3 cells expressing mK3 and Ld (WT, 1S, or 1K mutants or ∆CKST as shown in Fig. 2 A) were permeabilized and
incubated with reaction buffer containing ATP, E1, and Ube2j2.
Ld HCs were then precipitated and treated with 0.1 M NaOH.
As shown in Fig. 4 A, Ld ∆CKST molecules were not ubiquitinated by Ube2j2 in the presence of mK3, confirming that the
tail is indeed the site of ubiquitination. Furthermore, Ub conjugated by Ube2j2 on Ld 1S tails and not Ld 1K tails was found
to be labile in 0.1 M NaOH, which is consistent with their respective ester versus isopeptide bonds. Thus, these findings
provided additional evidence that Ube2j2 has the capacity to
cooperate with the mK3 ligase to form ester or isopeptide
bonds on the tails of HC substrates. Strikingly, the newly
formed Ub conjugates on WT Ld molecules (as detected in HA
blots) were also sensitive to the mild alkaline treatment, suggesting that mK3–Ube2j2 preferentially ubiquitinates S residues on WT HC tails even though K residues are available. To
extend these observations to nonpermeabilized cells, Ld HCs
were precipitated from the lysates of the same intact cell lines,
NaOH treated and blotted for Ub-HCs. Again, the Ub conjugates formed on WT Ld and Ld 1S were labile in mild alkaline
conditions (Fig. 4 B). Collectively, these findings demonstrate
that mK3 primarily interacts with Ube2j2 in vivo to preferentially ubiquitinate hydroxylated amino acids on WT HC even
when K residues are available.
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To determine whether Ube2j2 and/or Ube2d1 is required for
mK3-mediated HC ubiquitination and degradation, shRNAs
targeting specific E2s were introduced into WT3-Ld-mK3 cells
individually. Target gene expression was evaluated by quantitative RT-PCR (Fig. S3). shRNAs that yielded >70% inhibition
were selected for comparisons (Table S1). Compared with controls, the extent of ubiquitination of WT Ld in cells expressing
Ube2j2 shRNA (S#1) was lower, especially in the HC bands
containing more than two Ub moieties (Fig. 3 A, left). The specificity of this effect was confirmed by another Ube2j2 shRNA
(S#2) that targets a different sequence on Ube2j2 (Fig. 3 B,
left). In contrast to Ube2j2, inhibiting Ube2g1, Ube2g2, Ube2j1,
Ube2k, and Ube2n had no effect on the levels of Ld ubiquitination (Fig. 3, A [left] and B [left]; and not depicted), although
comparable levels of mK3 were expressed in each cell line
(Fig. 3, A [middle] and B [middle]). Concordant with the reduced
level of ubiquitination, the half-life of the Ld molecules was
dramatically increased in cells with depleted levels of Ube2j2
(Fig. 3, A [right] and B [right]). Thus, selective inhibition of
Ube2j2 by shRNA resulted in impaired Ub conjugation and
degradation of the HC substrates by mK3. In contrast, suppression
of Ube2d1 by shRNA had no obvious effect on ubiquitination
and stability of HCs (Fig. 3 A). Also, there was no additive
effect observed when Ube2d1 shRNA was coexpressed with
Ube2j2 shRNA (unpublished data). Thus, Ube2j2 is the uniquely
required E2 supporting mK3 function in vivo.
As noted in the previous paragraph, inhibition of Ube2j2
impaired polyubiquitination of HC substrates, yet Ub2-Ld forms
were still detected. This finding suggests that either another E2
besides Ube2j2 added the initial Ub moieties to HC substrates
or that the residual levels of Ube2j2 after inhibition were sufficient for initial ubiquitination but not chain assembly. To determine whether Ube2j2 is the primary E2 responsible for initial
ubiquitination as well as chain assembly on HC substrates,
WT3-Ld-mK3 cells expressing shRNA to Ube2j2 or Ube2d1
were permeabilized. The membrane fraction of these cells was
then incubated with ATP, HA-Ub, and E1. The ubiquitination of
Ld HCs, including Ub1-Ld and Ub2-Ld, was severely impaired
when Ube2j2 but not Ube2d1 was inhibited (Fig. 3 C), and this
impaired ubiquitination was completely reversed by adding recombinant Ube2j2 to the reaction (Fig. 3 C). Furthermore, the
same result was observed with cells expressing the 1S Ld mutant
and mK3 (Fig. 3 D). Thus, these data definitively demonstrate

that Ube2j2 is the primary E2 that is required for mK3-induced
initial Ub conjugation and chain assembly on S residues of
HC substrates.

Contribution of deubiquitinating
enzymes (DUBs) to mK3-mediated
Ub conjugation of HC

DUBs could potentially contribute to the dominant ubiquitination of hydroxylated amino acids on the WT HCs by mK3 if
they preferentially cleave K-linked Ub conjugates rather than
S/T-linked Ub conjugates. To test this possibility, a similar experiment as in Fig. 4 A was conducted in the presence or absence
of Ub aldehyde (Ub-Al), a potent inhibitor for all C protease
families of DUBs (Pickart and Rose, 1986; Hershko and Rose,
1987). It should be noted that a few known DUBs belong to the
metalloprotease family and thus are not inhibited by Ub-Al, although the majority of DUBs discovered so far are C proteases
(Amerik and Hochstrasser, 2004). The results show that both
S- and K-linked ubiquitination on either 1S or 1K Ld molecules
conjugated by Ube2j2 and mK3 in a permeabilized cell system
were enhanced by the inhibition of DUB activity with Ub-Al
(Fig. 5 A), suggesting that the DUBs retained in permeabilized
cells cleave both K Ub and S Ub conjugates. Although the extent of enhancement of ubiquitination after DUB inhibition was
greater on 1K than 1S mutant HC substrates, the signal of 1S
Nonconventional ubiquitination by Ube2j2–mK3 • Wang et al.

659

Published November 30, 2009

Downloaded from jcb.rupress.org on January 29, 2015
Figure 3. Ube2j2 is required for mK3-induced HC ubiquitination and degradation. (A) WT3 cells expressing WT Ld and mK3 were transduced by lentivirusbased shRNA targeting one of the following Ub-conjugating enzymes: Ube2d1, Ube2g1, Ube2g2, Ube2j1, or Ube2j2 (S#1). After incubation with 50 µM
MG132 for 2 h, Ld HCs were precipitated from these cells and followed by SDS-PAGE and blotting with anti-Ub and anti-Ld antibodies. The -actin and
mK3 blots in the middle panel were included to show a similar amount of input lysate and mK3 in each cell line. In the right panel, selected cell lines from
the left panel were incubated for 24 h with 125 U/ml IFN-, pulse labeled with [35S]Cys/Met, and chased for the indicated times with unlabeled Cys/Met.



660

JCB • VOLUME 187 • NUMBER 5 • 2009

Published November 30, 2009

Figure 4. Ub conjugates on WT Ld molecules
induced by mK3 are sensitive to mild alkaline
treatment. (A) WT3 cells expressing mK3 and
WT Ld or one of the mutants Ld 1K, Ld 1S, or Ld
CKST were permeabilized, cytosol depleted,
and incubated with E1, Ube2j2, and HA-Ub.
After treatment with PBS or 0.1 M NaOH for
1 h at 37°C, Ld HC precipitates from these cells
were neutralized and resolved by reducing
SDS-PAGE and then blotted with anti-HA and
anti-Ld. A background Ig heavy chain band can
be seen in the blot. Data are representative
of two independent experiments. (B) Ld HCs
were precipitated from cells used in A without
permeabilization. After NaOH treatment, SDSPAGE and immunoblotting were conducted as
in A, except using anti-Ub to visualize ubiqui
tinated Ld HC. The -actin and mK3 blots on the
right were included to show a similar amount
of input lysate and mK3 in each cell line. Data
are representative of three independent experi
ments. (A and B) Molecular mass is indicated
in kilodaltons. IP, immunoprecipitation.
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ubiquitination was consistently stronger than that of 1K molecules regardless of whether DUB inhibitor was present or not
(Fig. 5 A, lane 3 vs. lane 1 or lane 4 vs. lane 2). This finding
further suggests that Ube2j2–mK3 favors the ubiquitination of
S/T residues on HCs. Importantly, this preference can neither be
attributed to the position of acceptor residue because the same
position was used for 1K and 1S mutants nor by differential susceptibility of hydroxylated versus amide-linked Ub conjugates
to DUB activity. It is also notable that there was a marked accumulation of Ub conjugates on WT Ld molecules in the presence
of Ub-Al (Fig. 5 B, lane 2 vs. lane 1), and these conjugates remained sensitive to NaOH treatment (Fig. 5 B, lane 6 vs. lane 2).
This observation demonstrates that dominant S/T-linked ubiquitination on WT Ld molecules is not the consequence of differential DUB activity but rather preferential S/T ubiquitination
by Ube2j2–mK3. This conclusion is further supported by direct
comparison of alkaline sensitivity of ubiquitinated WT HCs

catalyzed by Ube2j2 with Ube2d1. In the presence of Ub-Al,
in contrast to Ube2j2–mK3-catalyzed Ub-Ld conjugates, which
were sensitive to NaOH treatment, Ub-Ld molecules conjugated
by Ube2d1–mK3 were stable under the same conditions (Fig.
5 C, lane 3 vs. lane 4), thus clearly demonstrating that these
two E2s interact with mK3 to ubiquitinate different residues on
the WT HCs. These findings show that Ube2j2 is directly responsible for the preferential ubiquitination of S/T residues on
WT HC substrates. In addition, it is worthy to note that S/T
Ub conjugates, once formed, may be more resistant to DUBmediated cleavage than K Ub conjugates. This is indicated by
the greater enhancement of K Ub conjugates than S Ub conjugates upon DUB inhibition (Fig. 5 A, compare lane 2 vs. lane 1
with lane 4 vs. lane 3). Preferential ubiquitination of S/T residues on WT HCs may be a strategy developed by -HV68 to
effectively down-regulate major histocompatibility complex I
molecules, thus evading CD8 cell detection.

Ld precipitates were resolved by SDS-PAGE and visualized by autoradiography. Relative band intensities from the gels are plotted as a percentage of the
intensity at time 0 for each cell line. Data are representative of three independent experiments. (B) WT3 cells expressing WT Ld and mK3 were transduced
by retrovirus-based shRNA targeting Ube2j2 (S#2) or Ube2n or by an empty vector. The ubiquitination and degradation of Ld HCs were determined by
immunoblotting and pulse–chase experiments as in A. Data are representative of three independent experiments. (C) Selected cells used in A and B were per
meabilized, cytosol depleted, and incubated with E1 or E1 + Ube2j2 in the presence of ATP, HA-Ub, and Ub-Al. Precipitated Ld molecules were resolved by
SDS-PAGE and blotted for newly ubiquitinated Ld by anti-HA. An anti-Ld blot was included to show the level of Ld molecules in each cell line. (D) Same as in
C except that WT3 cells expressing 1S Ld and mK3 were used. (A–D) Molecular mass is indicated in kilodaltons. IB, immunoblot; IP, immunoprecipitation.
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Figure 5. Ube2j2–mK3 favors ubiquitination of S residues over K residues on the tail of HC substrates. (A) WT3 cells expressing mK3 and Ld 1K (329K)
or Ld 1S (329S) were permeabilized, cytosol depleted, and incubated with E1, Ube2j2, and HA-Ub in the presence or absence of 2 µM Ub-Al, a DUB
inhibitor. After treatment with PBS or NaOH for 45 min, Ld HC precipitates from these cells were neutralized and resolved by reducing SDS-PAGE and
then blotted with anti-HA and anti-Ld. Background Ig heavy chain bands can be seen in the blot. Quantification of Ub2-Ld bands from PBS treatment in
the gel is shown in the graph. Samples from cytosolic proteins and pellets of each line were blotted to verify an equal amount of mK3 expression (right).
(B) WT3 cells expressing mK3 and WT Ld or Ld 1K were permeabilized and incubated with E1, Ube2j2, and HA-Ub in the presence or absence of Ub-Al.
All other steps were performed as in A. (C) Same as in A, except permeabilized cells expressing mK3 and WT Ld were incubated with either Ube2d1
or Ube2j2 in the presence of Ub-Al. Data shown are representative of two independent experiments. (A–C) Molecular mass is indicated in kilodaltons.
IP, immunoprecipitation.
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Sequences in addition to the RING-CH
domain of the ligase are critical
for ubiquitination of substrates via
nonisopeptide bonds

Discussion
Nonisopeptide bond–linked substrate ubiquitination was initially shown with homologous RING-CH–type viral ligases
from KSHV and -HV68. More specifically, the kK3 and kK5
ligases of KSHV were shown to ubiquitinate C residues on HC,
thereby inducing their rapid endocytosis and degradation in the
lysosome (Cadwell and Coscoy, 2005, 2008). In addition, we
demonstrated that ubiquitination of HCs by -HV68 ligase
mK3 can occur via an ester bond to hydroxylated amino acids
(S or T), resulting in ERAD of the HCs (Wang et al., 2007).
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Unlike mK3, kK3 and kK5 ligases ubiquitinate HCs in a post-ER
compartment, resulting in their rapid endocytosis and lysosomal degradation (Lehner et al., 2005). The cognate E2s of
kK3 have been identified as Ubc5b/c (Ube2d2/3) and Ubc13
(Ube2n), which catalyze a K63-linked poly-Ub chain on the tail
of the HCs (Duncan et al., 2006). Moreover, both kK3 and kK5
can facilitate Ub conjugation of C and K residues (Cadwell and
Coscoy, 2005, 2008) and not S/T residues like mK3. Whether
the same or different E2s facilitate a C ubiquitination versus
a K ubiquitination by kK3 and kK5 has not yet been reported.
Nevertheless, the fact that mK3 and kK3/kK5 have similar
overall structures with highly homologous RING-CH domains
make them valuable probes for understanding the determinants and
consequences of specific E2–E3 interactions with each other
and with substrates. To determine the importance of the RING-CH
domain in E2 selection and the potential to ubiquitinate
hydroxylated residues, the RING domains of kK3 and kK5 were
each swapped into mK3. Each of these RING swap constructs
was introduced into cells expressing WT Ld or Ld mutants with
only C, K, S, or T residues available in the tail. As expected,
both kK3 and kK5 RINGs in the context of mK3-mediated robust ubiquitination of K, S, or T but not C in tails of the HC in
these cells (unpublished data). Their lack of ability to efficiently
conjugate C residues is not caused by the position of the C residue because other positions were tested, including sites proximal to the C terminus of the tail, as favored by intact kK3 ligase
(Herr et al., 2009). Thus, in the context of mK3, the RING domains of kK3 or kK5 no longer supported ubiquitination of
C residues like their intact ligases but facilitated S or T ubiquitination like intact mK3. Furthermore, in our permeabilized cell
system, Ube2j2 and not Ube2n interacted with kK3 or kK5
RING swaps to greatly enhance the ubiquitination on an S residue of the tail of HC (Fig. 6 A, left and right, respectively).
Accordingly, the Ub chains formed on the tail of Ld 1S molecules
in kK3 or kK5 swap–expressing cells were Ub K48 and not K63
dependent (Fig. 6 B), which is the same as what was observed
with WT mK3 (Fig. S4). Collectively, these data demonstrate
that sequences outside the RING domain of mK3 ligase are
critical determinants for which E2 is recruited, which non-K
residues can be ubiquitinated, and which linkage is used for
poly-Ub chain assembly.

These findings have raised considerable interest in understanding
the molecular basis and physiological importance of this nonconventional ubiquitination. In this study, we show that Ube2j2
can promote the ubiquitination on HC mutants having only 1S
or only 1K on the tail. Consistent with their ester linkage, Ub
conjugates on the 1S mutant were substantially more labile to
the mild alkaline treatment than Ub conjugates on 1K mutants.
Furthermore, regardless of whether S or K residues of substrate
HCs were ubiquitinated, the poly-Ub chain was assembled with
K48 linkages (Fig. S4). Thus, these findings demonstrate that
a specialized Ub-conjugating enzyme is not required; instead,
the same E2 cooperates with mK3 to promote either ester bonds
or isopeptide bonds between Ub and substrate. We previously
found that there are no sequence constraints around either K or
S/T ubiquitination sites on HC substrates but that a certain proximity from the ER membrane is required (Wang et al., 2007;
Herr et al., 2009). These combined findings suggest a model
whereby the correct position or orientation of Ube2j2 relative
to the substrate is imposed by mK3 and that this is a common
requirement for both K and S/T ubiquitination. Surprisingly we
find that Ub conjugates on the WT Ld molecules mediated by
mK3–Ube2j2 are mainly linked via hydroxylated residues even
though WT Ld contains multiple Ks in the tail. This S/T ubiquitination preference by Ube2j2 is observed when C protease
DUB activity is inhibited and thus cannot be explained by DUB
more efficiently cleaving K-linked Ub conjugates. Given the
fact that there has been increasing evidence showing that nonconventional ubiquitination may occur on multiple substrates
in different cellular pathways, it is very likely an underappreciated mechanism. The flexibility of the selection of conjugation
residues may lead to more efficient Ub modification and would
benefit protein quality control for proteins having no K residues
accessible for ubiquitination. Furthermore, because S or T residues are also sites of phosphorylation, it is attractive to speculate that there is cross talk between two major posttranslational
modifications, ubiquitination and phosphorylation.
The mechanistic basis for the preferential S/T ubiquitination of substrates by Ube2j2–mK3 remains undefined.
However, the transmembrane domain (TMD) of Ubc6p has
been shown to play a dominant role in its ER localization and
is required for its in vivo function (Chen et al., 1993; Yang
et al., 1997). Interestingly, in this study, we show that soluble
Ube2j2 in which the TMD is deleted is capable of restoring
the Ub conjugation of S residues on HC substrates after inhibition of native Ube2j2 by shRNA. Thus, the TMD of Ube2j2
is not required for non-K ubiquitination and is not likely to
be involved in its interaction with mK3. However, the TMD
may facilitate the localization of Ube2j2 in the ER, which
is compensated by the overexpression of soluble Ube2j2
in a permeabilized cell system. It should be noted that we
were not able to coprecipitate Ube2j2 with mK3, suggesting
that their interaction may be transient. Such a transient
interaction would contrast with the strong binding of the E3
ligase gp78 to Ube2g2, as mediated by its G2BR domain
(Chen et al., 2006). Nevertheless, mK3 is the first E3 ligase
in mammals found to interact with Ube2j2 and promote
the ubiquitination and ERAD of its substrate. This defined
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Figure 6. The kK3 and kK5 RINGs in the context of mK3 interact with Ube2j2 to promote the formation of K48-linked Ub chain on S residues of the HCs.
(A) kK3 or kK5 RING-mK3 chimeric molecules were expressed in WT3–Ld 1S cells. After permeabilization and depletion of cytosolic proteins, aliquots of
these cells were incubated with no enzyme, E1 only, or E1 plus one of the two E2s in the presence of ATP and HA-Ub. Ld HCs were immunoprecipitated and
blotted as indicated. (B) Aliquots of the cells used in A were incubated with ATP, E1, and WT or mutant HA-Ub in an ubiquitination assay of permeabilized
cells as described in A. Immunoprecipitation (IP) of Ld and blotting by anti-HA (top) or anti-Ub (middle) antibodies shows newly formed Ub-Ld HCs and total
Ub-Ld HCs, respectively. The conjugates formed by HA-Ub are in red. (A and B) Molecular mass is indicated in kilodaltons. IB, immunoblot.

E2–E3–substrate interaction will be a foundation for future
functional characterization of Ube2j2 as well as dissection of
the mechanism of S/T ubiquitination.
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Interestingly, in our permeabilized cell assays, a second
E2, Ube2d1, supported mK3-induced ubiquitination of HC.
However, in contrast to Ube2j2, Ube2d1 facilitated ubiquitination
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2006; Mueller et al., 2008). Furthermore, it was recently found
that Ube2g2 alone can interact with gp78 in vitro to transfer a
preassembled K48-linked Ub chain to a substrate (Li et al.,
2007). Our study shows that both Ube2d1 and Ube2j2 are capable of interacting with mK3 to facilitate K48-linked poly-Ub
conjugation to the HCs (Fig. S4 B). However, in vivo, only
Ube2j2 is primarily required for mK3 function because inhibition of Ube2j2 alone impaired HC ubiquitination and degradation, whereas inhibition of Ube2d1 in vivo had no such effect.
Given the fact that Ube2d family members have never been
found in association with an ER membrane E3, it is possible
that the subcellular localization of Ube2d1 prevents its participation in ERAD. Alternatively, because S residues are the primary sites of ubiquitination on WT Ld tails, only depletion of
Ube2j2 and not Ube2d1 would be expected to impair mK3mediated ubiquitination and ERAD of HC substrates. In support
of this model, inhibition of Ube2j2 strikingly impairs HC ubiquitination, including Ub1-Ld forms on the WT HC and Ub conjugation on the 1S HC mutant. All of these Ub conjugates were
found to be sensitive to mild alkaline treatment, which is consistent with ester linkage. Thus, our data demonstrate that
Ube2j2 is primarily responsible for initial ubiquitination and
Ub chain assembly on HC substrates.
Our findings also have implications on the mechanism
of mK3-induced Ub chain assembly. Interestingly, although
Ube2j2–mK3 primarily ubiquitinates hydroxylated amino acids
on Ld substrates, it promotes a K48-linked poly-Ub chain. This
suggests that the determinants for attachment of the initial Ub
and assembly of the Ub chain are different. Curiously, in this
and other studies of mK3 ubiquitination by us and others
(Boname and Stevenson, 2001; Wang et al., 2007), Ub1 modifications were only weakly detected relative to predominant Ub2
and Ub3 polychains on HC substrates. However, Ub1-Ld forms
were clearly observed along with the overall increase in ubiquitination seen after inhibition of C protease DUBs. Thus, Ub1-HC
forms may be transient, reflecting rapid chain elongation
which is retarded in the presence of DUBs. This observation is
similar to a study with the yeast cullin-RING Ub ligase SCF
(Skp1–Cul1–F box protein) and Ub-conjugating enzyme Cdc34
(Petroski and Deshaies, 2005). SCF interacts with a single E2,
Cdc34, to catalyze both the attachment of the first Ub and elongation of a specific Ub chain on substrate. However, these two
reactions occur with strikingly different kinetics in which the
first step is relatively slow followed by rapid chain elongation
(Petroski and Deshaies, 2005). Alternatively, Ub chain assembly by mK3 may preferentially initiate with the addition of two
Ub moieties. Such a strategy would be similar to that of gp78–
Ube2g2 (Li et al., 2007, 2009). It was recently shown that ERassociated E3 ligase gp78 interacting with Ube2g2 mediated the
attachment of preassembled K48-linked Ub chain to substrate
by the formation of a gp78–Ube2g2 hetero-oligomer (Li et al.,
2009). Although the precise molecular strategy used by mK3–
Ube2j2 for Ub assembly is currently unknown, the predominance and specificity by which mK3–Ube2j2 interacts with HC
substrates will allow us to further dissect this process. In summary, we identify Ube2j2 as the primary E2 required for mK3
function. Mechanistically, our findings demonstrate that Ube2j2
Nonconventional ubiquitination by Ube2j2–mK3 • Wang et al.
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on Ld 1K molecules but not on Ld 1S molecules in the presence of mK3. In addition, Ube2d1–mK3-promoted Ub conjugates on the WT HCs were stable in mild alkaline conditions,
confirming an isopeptide bond linkage. These results indicate
that mK3-recruited Ube2d1 can only catalyze the formation of
isopeptide bonds between Ub and substrate but not ester bonds.
Different from Ube2j2, which has a C-terminal extension and a
TMD, Ube2d1 is comprised exclusively of the core catalytic
domain (Scheffner et al., 1994). Ube2d1 has been shown to
have broad E3-interacting activity, including HECT (homologous to the E6-AP C terminus)-, RING-, and U box–type E3s,
to promote Ub conjugation on K residues of substrates (Lorick
et al., 2005). In addition, Grou et al. (2008) recently reported
that all three closely related Ube2d family members, Ube2d1,
-2, and -3, can support ubiquitination of a C residue on Pex5p,
a peroxisomal import receptor. In yeast, this process is mediated
by a specialized Ub-conjugating enzyme, Pex4p (Williams et al.,
2007). These findings suggest that Ube2d members have the
potential to catalyze both K and non-K ubiquitination. However, in the Grou et al. (2008) study, Ube2d members were only
shown to mediate the ubiquitination on C residues of Pex5p,
and the E3 ligase has not been defined. Therefore, it is not clear
whether these Ube2d members can catalyze both types of ubiquitinations when interacting with the same E3. Furthermore,
thiolesteration between C residues and Ub is a standard reaction
used during charging of E1, E2, or HECT-type E3 with Ub.
Thus, the question remains whether an E2 capable of promoting
thiolesteration can also catalyze the addition of Ub to hydroxylated amino acids. In this study, we clearly demonstrate that
Ube2d1 is capable of mK3-induced HC ubiquitination on
K residues but lacks the ability to ubiquitinate S residues. The
mechanistic implication of these findings is that not all E2s
capable of interacting with mK3 can catalyze both K and S/T
ubiquitination, implying that non-K ubiquitination requires a
specific E2–E3 interaction. It should be noted that among seven
E2s tested in our system, Ube2d1 shares more predicted E3
interaction sites with Ube2j2 than the other E2s tested (4/5 vs.
≤3 conserved residues). Furthermore, comparison of available
structures of homologues of mouse Ube2d1 and Ube2j2 shows
a similar E3 interaction surface, but they vary around their catalytic C residues.
A single E3 ligase can interact with more than one E2, as
demonstrated in several in vitro and a few in vivo studies (Chen
et al., 1993; Christensen et al., 2007; Rodrigo-Brenni and
Morgan, 2007; Windheim et al., 2008). This redundancy adds
another apparent layer of regulation in Ub modification. However, precise consequences of two or more E2s cooperating with
a particular E3 remains largely undefined. Recently proposed
models have speculated that certain E2s can primarily catalyze
the conjugation of the initial Ub moiety to the substrate, whereas
other E2s assemble the poly-Ub chain with either K48 or K63
linkages (Christensen et al., 2007; Windheim et al., 2008).
Whether this sequentially acting E2 model also functions in
ERAD is currently unknown. Although ERAD-implicated E3
ligases have been shown to interact with more than one E2, it is
unclear whether these distinct E2s combine to polyubiquitinate
substrates (Bays et al., 2001; Kikkert et al., 2004; Arteaga et al.,
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in the context of mK3 adds the initial Ub primarily to S residues
of the HCs and then assembles a K48-linked poly-Ub chain,
which leads to the ERAD of the HCs.

Materials and methods
Cell lines
Murine cell line B6/WT3 (WT3; H-2b) was described previously (Wang
et al., 2004). The Vpack vector system (Agilent Technologies) and vectors
pHR’8.2∆R and pCMV-VSV-G (provided by S. Stewart, Washington Uni
versity School of Medicine, St. Louis, MO) were used to produce retrovirus
and lentivirus in 293T cells (DuBridge et al., 1987). Cells transduced by
pMSCV.IRES.neo (pMIN)-, pSRPU6-, or pLKO.1-based constructs were se
lected by corresponding antibiotics, whereas GFP+ cells from pMSCV.IRES.
GFP (pMIG)-transduced lines were enriched by cell sorting. Where indi
cated, cells were cultured for 24 h with 125 U/ml of mouse IFN- (Invitro
gen) and for 2–3 h with 50–60 µM of proteasome inhibitor MG132
(Boston Biochem) before harvesting with trypsin-EDTA.

Antibodies
Antibodies to mK3 and Ld (30-5-7 and 64-3-7) were previously described
(Smith et al., 1992; Lybarger et al., 2003). Antibodies to Ub (P4D1), -actin
(AC-74), Ube2k, Ube2n, and HA.11 (clone 16B12) were purchased from
Santa Cruz Biotechnology, Inc., Sigma-Aldrich, Cell Signaling Technology,
AnaSpec, and Covance, respectively.
Immunoprecipitation and immunoblots
Cells were lysed in PBS buffer containing 1% NP-40, 20 mM iodoacetamide
(Sigma-Aldrich), and protease inhibitors (complete mini [Roche] and 0.4 mM
PMSF [Sigma-Aldrich]). Postnuclear lysates were incubated with protein A–
Sepharose 4B beads (Sigma-Aldrich) and antibodies. After washing beads
four times with PBS/iodoacetamide buffer containing 0.15% NP-40, immuno
precipitates were eluted from protein A by boiling 3–5 min in lithium dodecyl
sulfate sample buffer (Invitrogen). For Endo H treatment, immunoprecipitates
were eluted in 10 mM Tris-HCl, pH 6.8, with 0.5% SDS; the eluates then were
mixed with an equal volume of 100 mM Na acetate, pH 5.4, and incubated
with 1 µU Endo H at 37°C for 2 h. For alkaline treatment, immunoprecipitates
were boiled in 0.5% SDS for 3 min followed by incubation in 0.1 M NaOH
for 1 h at 37°C. Immunoblotting was performed after SDS-PAGE separation of
precipitated proteins or postnuclear cell lysates on Immobilon-P transfer mem
branes (Millipore). Specific proteins were visualized by chemiluminescence
using the ECL system (Thermo Fisher Scientific).
Metabolic labeling and pulse–chase
After 30 min of preincubation in Cys- and Met-free medium (MEM-Earle’s
with 5% dialyzed FCS), cells were pulse labeled with Express [35S]Cys/
Met labeling mix (PerkinElmer) at 200 µCi/ml for 15 min. Chase was initi
ated by the addition of an excess of unlabeled Cys/Met (5 mM each).
Immunoprecipitation was performed as described in the previous section.
Immunoprecipitates were separated by SDS-PAGE and revealed by auto
radiography. Densities of the specific bands were analyzed using ImageJ
software (National Institutes of Health).
Cell permeabilization and ubiquitination
A method described by Shamu et al. (1999) was adopted with modifica
tion. In brief, after detachment by trypsin-EDTA and washing with PBS
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Recombinant E2s and HA-Ub proteins
Recombinant proteins used in this study, including mouse Ube2g1,
Ube2g2, soluble Ube2j1 (1–285 aa), soluble Ube2j2 (1–226 aa),
Ube2k, HA-Ub, and its mutants, were expressed as GST fusion proteins
in E. coli (BL21-CODONPLUS-RIL; Agilent Technologies) by pGEX4T (GE
Healthcare). The GST fusion proteins were purified with glutathione
beads (GE Healthcare) from the bacteria lysates according to the manu
facturer’s instructions. The recombinant proteins were cleaved from the
beads using thrombin (Sigma-Aldrich). The activity of purified recombi
nant E2s was assessed using a thiolester formation assay and compared
with the commercial E2s UbcH5a and His6-UbcH13–Uev1a complex
(Boston Biochem), which have the same amino acid sequence as mouse
Ube2d1 and Ube2n. Purified recombinant HA-Ub proteins possessing
two vector-derived amino acid remains (GS) at the N terminus were com
pared with commercial HA-Ub (Boston Biochem) in a thiolester formation
assay with functional E2. Aliquots of the aforementioned purified proteins
were stored at 80°C in 50 mM Tris-HCl, pH 8.0, 150 mM KCl, 2 mM
MgCl2, and 5% glycerol.
Online supplemental material
Fig. S1 shows that ubiquitination of HCs in permeabilized cells is depen
dent on the RING domain of mK3. Fig. S2 shows that the recombinant E2s
used in this study had similar enzymatic activity and protein level, as deter
mined by in vitro thiolester formation and silver stain. Fig. S3 shows the in
hibition by shRNA of targeted E2s, as determined by quantitative RT-PCR.
Fig. S4 shows that mK3-facilitated poly-Ub chains on either S or K residues
of HCs are dependent on K48 of Ub. Table S1 shows the shRNA sequences
used in this study. Online supplemental material is available at http://
www.jcb.org/cgi/content/full/jcb.200908036/DC1.
We thank Dr. Yihong Ye for helpful advice, Drs. Yunfeng Feng and Matt Walter
for help with the shRNA approach, and Dr. Janet Connolly for critical reading
of the manuscript.
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